Monica S Sierra1, David Forman2. 1. International Agency for Research on Cancer, Lyon, Rhone, France. Electronic address: sierram@fellows.iarc.fr. 2. International Agency for Research on Cancer, Lyon, Rhone, France.
Abstract
RATIONALE AND OBJECTIVE: The colorectal cancer (CRC) burden is increasing in Central and South American due to an ongoing transition towards higher levels of human development. We describe the burden of CRC in the region and review the current status of disease control. METHODS: We obtained regional- and national-level incidence data from 48 population-based cancer registries in 13 countries, as well as cancer deaths from the WHO mortality database for 18 countries. We estimated world population age-standardized incidence (ASR) and mortality (ASMR) rates per 100,000 person-years for 2003-2007 and the estimated annual percentage change for 1997-2008. RESULTS: The CRC rate in males was 1-2 times higher than that in females. In 2003-2007, the highest ASRs were seen in Uruguayan, Brazilian and Argentinean males (25.2-34.2) and Uruguayan and Brazilian females (21.5-24.7), while El Salvador had the lowest ASR in both sexes (males: 1.5, females: 1.3). ASMRs were<10 for both sexes, except in Uruguay, Cuba and Argentina (10.0-17.7 and 11.3-12.0). CRC incidence is increasing in Chilean males. Most countries have national screening guidelines. Uruguay and Argentina have implemented national screening programs. CONCLUSION: Geographic variation in CRC and sex gaps may be explained by differences in the prevalence of obesity, physical inactivity, diet, smoking and alcohol consumption, early detection, and cancer registration practices. Establishing optimal CRC screening programs is challenging due to lack of healthcare access and coverage, funding, regional differences and inadequate infrastructure, and may not be feasible. Given the current status of CRC in the region, data generated by population-based cancer registries is crucial for cancer control planning.
RATIONALE AND OBJECTIVE: The colorectal cancer (CRC) burden is increasing in Central and South American due to an ongoing transition towards higher levels of human development. We describe the burden of CRC in the region and review the current status of disease control. METHODS: We obtained regional- and national-level incidence data from 48 population-based cancer registries in 13 countries, as well as cancer deaths from the WHO mortality database for 18 countries. We estimated world population age-standardized incidence (ASR) and mortality (ASMR) rates per 100,000 person-years for 2003-2007 and the estimated annual percentage change for 1997-2008. RESULTS: The CRC rate in males was 1-2 times higher than that in females. In 2003-2007, the highest ASRs were seen in Uruguayan, Brazilian and Argentinean males (25.2-34.2) and Uruguayan and Brazilian females (21.5-24.7), while El Salvador had the lowest ASR in both sexes (males: 1.5, females: 1.3). ASMRs were<10 for both sexes, except in Uruguay, Cuba and Argentina (10.0-17.7 and 11.3-12.0). CRC incidence is increasing in Chilean males. Most countries have national screening guidelines. Uruguay and Argentina have implemented national screening programs. CONCLUSION: Geographic variation in CRC and sex gaps may be explained by differences in the prevalence of obesity, physical inactivity, diet, smoking and alcohol consumption, early detection, and cancer registration practices. Establishing optimal CRC screening programs is challenging due to lack of healthcare access and coverage, funding, regional differences and inadequate infrastructure, and may not be feasible. Given the current status of CRC in the region, data generated by population-based cancer registries is crucial for cancer control planning.
Authors: María Laura González; Natalia Causada-Calo; Juan Pablo Santino; Mev Dominguez-Valentin; Fabiana Alejandra Ferro; Inés Sammartino; Pablo Germán Kalfayan; Maria Alicia Verzura; Tamara Alejandra Piñero; Andrea Romina Cajal; Walter Pavicic; Carlos Vaccaro Journal: Fam Cancer Date: 2018-07 Impact factor: 2.375
Authors: Caroline Young; Henry M Wood; Ramakrishnan Ayloor Seshadri; Pham Van Nang; Carlos Vaccaro; Luis Contreras Melendez; Mayilvahanan Bose; Mai Van Doi; Tamara Alejandra Piñero; Camilo Tapia Valladares; Julieta Arguero; Alba Fuentes Balaguer; Kelsey N Thompson; Yan Yan; Curtis Huttenhower; Philip Quirke Journal: Genome Med Date: 2021-02-16 Impact factor: 11.117
Authors: Nelly Solis; Elizabeth Zavaleta; Patrik Wernhoff; Constantino Dominguez-Barrera; Mev Dominguez-Valentin Journal: Int J Environ Res Public Health Date: 2021-02-04 Impact factor: 3.390
Authors: Andrés López-Cortés; Santiago Guerrero; María Ana Redal; Angel Tito Alvarado; Luis Abel Quiñones Journal: Int J Mol Sci Date: 2017-05-23 Impact factor: 5.923
Authors: Désirée Schliemann; Nicholas Matovu; Kogila Ramanathan; Paloma Muñoz-Aguirre; Ciaran O'Neill; Frank Kee; Tin Tin Su; Michael Donnelly Journal: BMJ Open Date: 2020-06-11 Impact factor: 2.692